Thema
Journal Article
200
Research Support, Non-U.S. Gov't
99
Antibodies, Monoclonal
62
daratumumab
62
4Z63YK6E0E
59
Dexamethasone
54
7S5I7G3JQL
51
Review
49
Lenalidomide
43
F0P408N6V4
38
Research Support, N.I.H., Extramural
38
Multicenter Study
37
Multiple myeloma
33
Antineoplastic Agents
32
Randomized Controlled Trial
28
multiple myeloma
26
Bortezomib
25
Daratumumab
23
69G8BD63PP
21
Thalidomide
19
Clinical Trial, Phase III
18
4Z8R6ORS6L
16
Clinical Trial, Phase I
16
carfilzomib
16
Letter
15
72X6E3J5AR
14
Receptors, Chimeric Antigen
14
Clinical Trial, Phase II
13
B-Cell Maturation Antigen
12
Antibodies, Monoclonal, Humanized
11
Antineoplastic Agents, Immunological
11
Klinische Studie
11
Oligopeptides
11
Minimal residual disease
9
Biomarkers, Tumor
8
Case Reports
8
Comparative Study
8
Proteasome Inhibitors
8
Relapsed/refractory multiple myeloma
8
Subcutaneous
8
Transplant
8
pomalidomide
7
ADP-ribosyl Cyclase 1
6
Biomarkers
6
D2UX06XLB5
6
EC 3.2.2.6
6
Melphalan
6
Q41OR9510P
6
Research Support, U.S. Gov't, P.H.S.
6
Antibodies, Bispecific
5
mehr ...